Eva González-Haba Peña-rekin lankidetzan egindako argitalpenak (4)

2014

  1. Validaciónde polimorfismos genéticos asociados a toxicidad al tratamiento quimioteŕapico en pacientes de cancer colorrectal

    Farmacia Hospitalaria, Vol. 38, Núm. 4, pp. 283-290

2013

  1. Differential toxicity biomarkers for irinotecan- and oxaliplatin-containing chemotherapy in colorectal cancer

    Cancer Chemotherapy and Pharmacology, Vol. 71, Núm. 6, pp. 1463-1472

  2. Erratum: Differential toxicity biomarkers for irinotecan and oxaliplatin containing chemotherapy in colorectal cancer (Cancer Chemotherapy and Pharmacology (2013) 71 (1463-1472) DOI: 10.1007/s00280-013-2145-6)

    Cancer Chemotherapy and Pharmacology

2010

  1. ABCB1 gene polymorphisms are associated with adverse reactions in fluoropyrimidine-treated colorectal cancer patients

    Pharmacogenomics, Vol. 11, Núm. 12, pp. 1715-1723